Gene Biotherapeutics, Inc. Total Liabilities
Gene Biotherapeutics, Inc. had Total Liabilities of $5.14 million as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2022-04-14
- 2020-12-31: Liabilities $5.14M.
- 2020-09-30: Liabilities $5.05M.
- 2020-06-30: Liabilities $5.02M.
- 2020-03-31: Liabilities $5.15M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2020-12-31 | $5.14M 10-K/A · filed 2022-04-14 | |
| 2020-09-30 | $5.05M 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $5.02M 10-Q · filed 2021-09-17 | |
| 2020-03-31 | $5.15M 10-Q · filed 2021-09-03 | |
| 2019-12-31 | $4.89M 10-K/A · filed 2022-04-14 | |
| 2019-09-30 | $6.35M 10-K · filed 2021-04-23 | |
| 2019-06-30 | $6.18M 10-K · filed 2021-04-23 | |
| 2019-03-31 | $5.94M 10-K · filed 2021-04-23 | |
| 2018-12-31 | $5.79M 10-K · filed 2021-04-23 | |
| 2018-09-30 | $5.63M 10-K · filed 2021-04-23 | |
| 2018-06-30 | $5.86M 10-K · filed 2021-04-23 | |
| 2018-03-31 | $5.58M 10-K · filed 2021-04-23 | |
| 2017-12-31 | $5.37M 10-K · filed 2021-04-23 | |
| 2017-09-30 | $4.99M 10-K · filed 2021-04-23 | |
| 2017-06-30 | $4.62M 10-K · filed 2021-04-23 | |
| 2017-03-31 | $4.32M 10-K · filed 2021-04-23 | $4.32M 10-Q · filed 2017-07-28 |
| 2016-12-31 | $4.40M 10-K · filed 2017-07-28 | |
| 2016-09-30 | $4.29M 10-Q · filed 2017-03-21 | |
| 2016-06-30 | $4.57M 10-Q · filed 2017-03-06 | |
| 2016-03-31 | $4.08M 10-Q · filed 2017-03-01 | |
| 2015-12-31 | $3.83M 10-K · filed 2017-07-28 | |
| 2015-09-30 | $3.41M 10-Q · filed 2016-10-27 | |
| 2015-06-30 | $3.04M 10-Q · filed 2016-08-29 | |
| 2015-03-31 | $2.72M 10-Q · filed 2015-06-18 | |
| 2014-12-31 | $2.43M 10-K · filed 2016-12-29 | |
| 2014-09-30 | $2.32M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $2.31M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $2.26M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.60M 10-K · filed 2015-05-22 | |
| 2013-09-30 | $1.18M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $1.23M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.25M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.44M 10-K · filed 2014-04-15 | |
| 2012-09-30 | $1.30M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.14M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.80M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.42M 10-K · filed 2013-04-05 | |
| 2011-09-30 | $1.44M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.81M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $2.08M 10-K · filed 2012-03-30 |